Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver physiology and pathology, Organ Transplantation Techniques and Outcomes, and Hepatocellular Carcinoma Treatment and Prognosis.
Towards a comprehensive definition of the human fascial system
Sex differences in murine MASH induced by a fructose-palmitate-cholesterol-enriched diet
DIAPH1 mediates progression of atherosclerosis and regulates hepatic lipid metabolism in mice
Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease
Intrahepatic microbes govern liver immunity by programming NKT cells
The Brain-Nose Interface: A Potential Cerebrospinal Fluid Clearance Site in Humans
Quantifying cerebrospinal fluid dynamics: A review of human neuroimaging contributions to CSF physiology and neurodegenerative disease
Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice
Etiology, Pathogenesis, Diagnosis, and Practical Implications of Hepatocellular Neoplasms
Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications
Pathologic, Molecular, and Prognostic Radiologic Features of Hepatocellular Carcinoma
Evidence for continuity of interstitial spaces across tissue and organ boundaries in humans
Lymphoepithelioma‐like neoplasm of the biliary tract with ‘probable low malignant potential’
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy
Expansion, in vivo–ex vivo cycling, and genetic manipulation of primary human hepatocytes
Lipid droplets disrupt mechanosensing in human hepatocytes
Innervation of the proximal human biliary tree
Invasive Ductular Reaction Operates Hepatobiliary Junctions upon Hepatocellular Injury in Rodents and Humans
Coordinated development of the mouse extrahepatic bile duct: Implications for neonatal susceptibility to biliary injury
Structure and Distribution of an Unrecognized Interstitium in Human Tissues
High Mobility Group Box‐1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice
Histology of portal vascular changes associated with idiopathic non‐cirrhotic portal hypertension: nomenclature and definition
Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.
Progression and regression of fibrosis in viral hepatitis in the treatment era: the Beijing classification
Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak “stable” patients on anti-HBV therapy
Second Harmonic Generation Reveals Subtle Fibrosis Differences in Adult and Pediatric Nonalcoholic Fatty Liver Disease
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment
Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury
Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation